Based on these considerations, we present an innovative bovine serum albumin (BSA)-based nanoparticle (NP) delivery system using an injectable thermosensitive hydrogel for the local delivery of BSA-Ce6-PTX (denoted as BCP) NPs, aimed at promoting synergistic combination therapy for pancreatic cancer. The gene discussed is ALB; the disease is familial pancreatic carcinoma.